Search results for “Propanoic Acid Derivatives” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 328 patents, we discovered top 88 key players by total patent application. Glaxosmithkline Intellectual Property Development Ltd., Encysive Pharmaceuticals, Inc., Kotobuki Pharmaceutical Co. Ltd. are dominant in this area. They take 20.43% of the total patent filing.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 23
Encysive Pharmaceuticals, Inc.
Texas, United States
Patent: 22
Kotobuki Pharmaceutical Co. Ltd.
Shizuoka-ken, Japan
Patent: 22
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 21
Pfizer Inc.
New York, United States
Patent: 17
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 14
Galenica SA
Greece
Patent: 13
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 10
Pharmacia Italia Spa
MILAN, Italy
Patent: 9
Valspar Industries, Inc.
Indiana, United States
Patent: 8
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 35 patents applied in the last 5 years. We discover 22 most active companies in this area. The fast-growing Alairion, Inc., DAIKIN INDUSTRIES Ltd., Kotobuki Pharmaceutical Co. Ltd. take 37.14% of patent filing during this period.
Alairion, Inc.
Massachusetts, United States
Patent: 8
DAIKIN INDUSTRIES Ltd.
Osaka-fu, Japan
Patent: 3
Kotobuki Pharmaceutical Co. Ltd.
Shizuoka-ken, Japan
Patent: 2
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 2
Aviara Pharmaceuticals, Inc.
Texas, United States
Patent: 2
Bayer Pharma AG
Berlin, Germany
Patent: 2
Arxada AG
Basel-Stadt, Switzerland
Patent: 1
Nippon Chemiphar Co., Ltd.
Tokyo-to, Japan
Patent: 1
Astex Therapeutics Ltd.
Cambridgeshire, United Kingdom
Patent: 1
Galenica SA
Greece
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 35 patents in last 5 years, we discover 14 new entrants. Alairion, Inc., Aviara Pharmaceuticals, Inc., Arxada AG are the most active new entrants in this area.
Alairion, Inc.
Massachusetts, United States
Patent: 8
Aviara Pharmaceuticals, Inc.
Texas, United States
Patent: 2
Arxada AG
Basel-Stadt, Switzerland
Patent: 1
Nippon Chemiphar Co., Ltd.
Tokyo-to, Japan
Patent: 1
Hyundai Pharmaceutical Co., Ltd.
South Korea
Patent: 1
Liaocheng University
Shandong Sheng, China
Patent: 1
University of Shizuoka
Shizuoka-ken, Japan
Patent: 1
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 1
Instituto Politecnico Nacional
Distrito Federal, Mexico
Patent: 1
Prelude Therapeutics, Inc.
Delaware, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 27 patents, we discovered top 11 universities and scientific research institutions by total patent application. Council of Scientific & Industrial Research, Instituto Politecnico Nacional, Shanghai Jiao Tong University are dominant in this area. They take 18.52% of the total patent filing.
Council of Scientific & Industrial Research
Delhi, India
Patent: 3
Instituto Politecnico Nacional
Distrito Federal, Mexico
Patent: 1
Shanghai Jiao Tong University
Shanghai Shi, China
Patent: 1
Ghent University
Oost-Vlaanderen, Belgium
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
South China University of Technology
Guangdong Sheng, China
Patent: 1
King Fahd University of Petroleum & Minerals
Saudi Arabia
Patent: 1
Vlaams Instituut voor Biotechnologie - Flanders Institute
Belgium
Patent: 1
University of Shizuoka
Shizuoka-ken, Japan
Patent: 1
Liaocheng University
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: